Publication | Closed Access

Final results of a phase I–II trial using ex vivo expanded autologous Mesenchymal Stromal Cells for the treatment of osteoarthritis of the knee confirming safety and suggesting cartilage regeneration

Tissue EngineeringRegenerative MedicineEngineeringMedicineCartilage RegenerationTranslational Tissue EngineeringCartilage DegenerationOsteoarthritisStem Cell ResearchStem-cell TherapyCartilage BiologyBiomedical EngineeringStem CellsMesenchymal Stem CellOrthopaedic SurgeryEx VivoPhase I–ii Trial